Notify me when Otto Erik files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| GLTO | Chemomab Therapeutics Ltd. | American Depository Shares, each of which represent twenty ordinary shares, no par value | 6.3% | 385,000 | -77% | Otto Erik | 10 Feb 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|